Patient Pathfinder: Clinical Trials
There are 249 active Kidney Cancer trials
Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH – Subprotocol V)
Study Type: Interventional Phase 2
A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004)
Study Type: Interventional Phase 2
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
Study Type: Interventional Phase 1
Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) Patients
Study Type: Observational
Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study
Study Type: Observational
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Study Type: Interventional Phase 1
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
Study Type: Interventional Phase 1
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Study Type: Interventional Phase 1
There are 249 active Kidney Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now